DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DBVT DBV Technologies S.A.

已收盘 04-28 16:00:00 EDT

20.80

+0.41

+2.01%

盘后20.80

+0.000.00%

16:04 EDT

最高21.05	最低20.57	成交量16.11万
今开20.81	昨收20.39	日振幅2.35%
总市值12.32亿	流通市值8.08亿	总股本5,921万
成交额335.51万	换手率0.41%	流通股本3,885万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DBVT","market":"US","secType":"STK","nameCN":"DBV Technologies S.A.","latestPrice":20.8,"timestamp":1777406400000,"preClose":20.39,"halted":0,"volume":161114,"hourTrading":{"tag":"盘后","latestPrice":20.8,"preClose":20.8,"latestTime":"16:04 EDT","volume":214,"amount":4451.2,"timestamp":1777406662519,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02010789602746445,"floatShares":38848000,"shares":59208500,"eps":-5.284455,"marketStatus":"已收盘","change":0.41,"latestTime":"04-28 16:00:00 EDT","open":20.81,"high":21.05,"low":20.57,"amount":3355107.266681,"amplitude":0.023541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.284455,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777449600000},"marketStatusCode":5,"adr":1,"adrRate":5,"listingDate":1413950400000,"exchange":"NASDAQ","adjPreClose":20.39,"preHourTrading":{"tag":"盘前","latestPrice":20.68,"preClose":20.39,"latestTime":"09:29 EDT","volume":4379,"amount":90980.087687,"timestamp":1777382963139,"change":0.29,"changeRate":0.014223,"amplitude":0.013242},"postHourTrading":{"tag":"盘后","latestPrice":20.8,"preClose":20.8,"latestTime":"16:04 EDT","volume":214,"amount":4451.2,"timestamp":1777406662519,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.69677,"impliedVol":2.936,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/DBVT","defaultTab":"news","newsList":[{"id":"2584670185","title":"Dbv Technologies盘中异动 早盘急速上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584670185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584670185?lang=zh_cn&edition=full","pubTime":"2025-11-17 23:23","pubTimestamp":1763392993,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日23时23分，Dbv Technologies股票出现波动，股价急速上涨5.36%。截至发稿，该股报13.95美元/股，成交量4953股，换手率0.01%，振幅2.79%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.11%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117232313976f251c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117232313976f251c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583072983","title":"Dbv Technologies盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583072983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583072983?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:33","pubTimestamp":1762957990,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日22时33分，Dbv Technologies股票出现异动，股价快速上涨5.26%。截至发稿，该股报14.04美元/股，成交量1.7001万股，换手率0.05%，振幅1.84%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.25%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223310a49caa67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112223310a49caa67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581011709","title":"Dbv Technologies盘中异动 早盘急速上涨7.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581011709?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:33","pubTimestamp":1762439601,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时33分，Dbv Technologies股票出现异动，股价急速上涨7.28%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Iovance Biotherapeutics, Inc.、Cytomed Therapeutics Limited、Pharming Group Nv涨幅较大，Osr Holdings, Inc.、Polyrizon Ltd.、Lunai Bioworks Inc.较为活跃，换手率分别为84.37%、11.27%、6.60%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Cartesian Therapeutics, Inc.、Sangamo Therapeutics, Inc.，振幅分别为20.60%、11.99%、11.78%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223321a6e63480&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223321a6e63480&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581716188","title":"Dbv Technologies盘中异动 急速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581716188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581716188?lang=zh_cn&edition=full","pubTime":"2025-11-04 23:45","pubTimestamp":1762271100,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日23时45分，Dbv Technologies股票出现异动，股价急速拉升5.33%。截至发稿，该股报15.01美元/股，成交量1.2776万股，换手率0.04%，振幅6.16%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.36%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发名为Viaskin的新技术平台来改变免疫治疗领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110423450094eee0bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110423450094eee0bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518272635","title":"Dbv Technologies盘中异动 股价大涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272635?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:30","pubTimestamp":1741613459,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时30分，Dbv Technologies股票出现波动，股价快速上涨8.25%。截至发稿，该股报4.52美元/股，成交量4.8497万股，换手率0.24%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213059abf2fb8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166262","title":"Dbv Technologies盘中异动 早盘股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166262?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:51","pubTimestamp":1741272707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时51分，Dbv Technologies股票出现异动，股价快速跳水5.63%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.67%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225147963c5191&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910072","title":"Dbv Technologies盘中异动 股价大跌5.35%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910072?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185043,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Dbv Technologies股票出现异动，股价大幅跳水5.35%。截至发稿，该股报4.07美元/股，成交量365股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223043989d4589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517098348","title":"Dbv Technologies盘中异动 下午盘大幅拉升8.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517098348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517098348?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:49","pubTimestamp":1741117758,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时49分，Dbv Technologies股票出现波动，股价大幅拉升8.33%。截至发稿，该股报4.29美元/股，成交量6073股，换手率0.03%，振幅5.05%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305034919989bf4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516341226","title":"Dbv Technologies盘中异动 股价大跌8.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341226?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012404,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Dbv Technologies股票出现波动，股价急速跳水8.99%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.21%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223324abe633f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514202563","title":"Dbv Technologies盘中异动 早盘股价大跌6.43%报3.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514202563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514202563?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:43","pubTimestamp":1740753830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时43分，Dbv Technologies股票出现异动，股价急速下挫6.43%。截至发稿，该股报3.93美元/股，成交量4017股，换手率0.02%，振幅0.41%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822435198967cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513722215","title":"Dbv Technologies盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722215?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:41","pubTimestamp":1740408083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时41分，Dbv Technologies股票出现波动，股价大幅下挫5.35%。截至发稿，该股报4.16美元/股，成交量2295股，换手率0.01%，振幅0.91%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.06%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224224124a25216cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513215896","title":"Dbv Technologies盘中异动 股价大涨7.98%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513215896?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:54","pubTimestamp":1740160498,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时54分，Dbv Technologies股票出现异动，股价大幅拉升7.98%。截至发稿，该股报4.60美元/股，成交量4995股，换手率0.02%，振幅9.15%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.44%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015458abd7daaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511487525","title":"Dbv Technologies盘中异动 股价大涨6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511487525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511487525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:32","pubTimestamp":1739457148,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时32分，Dbv Technologies股票出现波动，股价大幅拉升6.11%。截至发稿，该股报4.37美元/股，成交量625股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.17%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223228abcdb26b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510351579","title":"Dbv Technologies盘中异动 下午盘急速拉升6.65%报4.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510351579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510351579?lang=zh_cn&edition=full","pubTime":"2025-02-12 03:54","pubTimestamp":1739303644,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时54分，Dbv Technologies股票出现异动，股价快速拉升6.65%。截至发稿，该股报4.47美元/股，成交量9791股，换手率0.05%，振幅9.87%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为1.75%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212035404961f7be0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509200387","title":"Dbv Technologies盘中异动 大幅跳水6.44%报4.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509200387?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:26","pubTimestamp":1738866417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时26分，Dbv Technologies股票出现波动，股价快速跳水6.44%。截至发稿，该股报4.29美元/股，成交量1.6438万股，换手率0.08%，振幅1.53%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.19%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207022657a23bfed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457616","title":"Dbv Technologies盘中异动 早盘快速拉升9.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457616?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:30","pubTimestamp":1738679425,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时30分，Dbv Technologies股票出现波动，股价大幅拉升9.36%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.00%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223025987a4a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508142853","title":"Dbv Technologies盘中异动 大幅下跌9.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142853?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Dbv Technologies股票出现波动，股价快速下跌9.82%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.39%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238299616fce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032238299616fce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507961066","title":"Dbv Technologies盘中异动 大幅上涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507961066?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:33","pubTimestamp":1738337587,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时33分，Dbv Technologies股票出现异动，股价大幅拉升6.57%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为1.38%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123330798776713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013123330798776713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507447632","title":"Dbv Technologies盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507447632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507447632?lang=zh_cn&edition=full","pubTime":"2025-01-29 23:10","pubTimestamp":1738163432,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日23时10分，Dbv Technologies股票出现异动，股价大幅跳水5.80%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.53%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129231032abbc6290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129231032abbc6290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506126795","title":"Dbv Technologies盘中异动 早盘大幅下挫5.56%报4.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506126795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506126795?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:59","pubTimestamp":1738076340,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时59分，Dbv Technologies股票出现波动，股价急速下挫5.56%。截至发稿，该股报4.27美元/股，成交量3562股，换手率0.02%，振幅2.32%。Dbv Technologies股票所在的生物技术行业中，整体跌幅为0.01%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128225900a23274d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128225900a23274d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DBVT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dbvtechnologies.com;www.dbv-technologies.com","stockEarnings":[{"period":"1week","weight":-0.029},{"period":"1month","weight":0.0195},{"period":"3month","weight":-0.1657},{"period":"6month","weight":0.3406},{"period":"1year","weight":1.3904},{"period":"ytd","weight":0.0636}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DBV Technologies S.A.该公司于2002年3月29日根据法兰西共和国法律注册成立。该公司是一家临床阶段的专业生物制药公司，专注于通过开发名为Viaskin的新型技术平台来改变免疫治疗领域。该公司的治疗方法基于表皮免疫疗法，即EPIT，这是其使用Viaskin通过完整皮肤向免疫系统递送生物活性化合物的专有方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.061177},{"month":2,"riseRate":0.5,"avgChangeRate":-0.001378},{"month":3,"riseRate":0.5,"avgChangeRate":0.046363},{"month":4,"riseRate":0.583333,"avgChangeRate":0.085066},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.023241},{"month":6,"riseRate":0.363636,"avgChangeRate":0.035995},{"month":7,"riseRate":0.454545,"avgChangeRate":0.060449},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.030622},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.085227},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.114027},{"month":11,"riseRate":0.5,"avgChangeRate":0.015604},{"month":12,"riseRate":0.666667,"avgChangeRate":0.01819}],"exchange":"NASDAQ","name":"DBV Technologies S.A.","nameEN":"DBV Technologies SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DBV Technologies S.A.,DBVT,DBV Technologies S.A.股票,DBV Technologies S.A.股票老虎,DBV Technologies S.A.股票老虎国际,DBV Technologies S.A.行情,DBV Technologies S.A.股票行情,DBV Technologies S.A.股价,DBV Technologies S.A.股市,DBV Technologies S.A.股票价格,DBV Technologies S.A.股票交易,DBV Technologies S.A.股票购买,DBV Technologies S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DBV Technologies S.A.(DBVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DBV Technologies S.A.(DBVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}